Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Cost of Revenue
$1.05M
TTM · Period ending: · USD
ARMP Cost of Revenue
Latest reported$1.05Mperiod ending
Latest reported$1.05Mperiod ending
ARMP TTM Cost of Revenue ($0.00 → $1.05M)
TTM cost of revenue
High-resolution chart · PNG
ARMP cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 1,048,000 | |
| 823,000 | |
| 743,000 | |
| 1,123,000 | |
| 1,436,000 | |
| 1,385,000 | |
| 1,325,000 | |
| 1,238,000 | |
| 1,146,000 | |
| 1,031,000 | |
| 10,318,000 | |
| 19,594,000 | |
| 27,773,000 | |
| 36,593,000 | |
| 35,017,000 | |
| 30,262,000 | |
| 27,488,000 | |
| 23,693,000 | |
| 20,015,000 | |
| 20,181,000 | |
| 18,621,000 | |
| 16,044,000 | |
| 11,694,000 | |
| 7,016,000 | |
| 2,950,000 | |
| 302,000 | |
| 302,000 | |
| 98,000 | |
| 98,000 | |
| 98,000 | |
| 195,000 | |
| 193,000 | |
| 286,000 | |
| 286,000 | |
| 189,000 | |
| 93,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -610,000 | |
| -1,045,000 | |
| -1,423,000 | |
| -1,776,000 | |
| -1,666,000 | |
| -1,631,000 | |
| -1,553,000 | |
| -1,600,000 | |
| -1,500,000 | |
| -1,400,000 | |
| -1,600,000 | |
| -1,600,000 | |
| -1,200,000 | |
| -900,000 |